Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Reply to M. Tanaka et al

Sara M Tolaney1, Ann H Partridge1, Eric P Winer1

  • 1Sara M. Tolaney, MD, MPH, Ann H. Partridge, MD, MPH, Eric P. Winer, MD, and Ian E. Krop, MD, PhD, Dana-Farber Cancer Institute, Boston, MA, Harvard Medical School, Boston, MA.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|September 10, 2021
PubMed
Summary

No abstract available in PubMed .

Related Experiment Videos

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Avutometinib, Abemaciclib, and Fulvestrant in Patients with HR+/HER2- Metastatic Breast Cancer Previously Treated with CDK4/6 Inhibitor: A Single-Arm Phase I Trial.

Clinical cancer research : an official journal of the American Association for Cancer Research·2026
Same author

Longitudinal multi-platform profiling reveals temporal dynamics of HER2, TROP2, PD-L1 and tumor-infiltrating lymphocytes in triple-negative breast cancer.

medRxiv : the preprint server for health sciences·2026
Same author

Pregnancy history, recency of childbirth, and outcomes in young women with early-stage breast cancer.

Journal of the National Cancer Institute·2026
Same author

Carboplatin with or without nivolumab in metastatic triple-negative breast cancer: a randomized phase II trial.

Nature communications·2026
Same author

Single-cell transcriptomics reveals immune landscape dynamics in metastatic hormone receptor-positive breast cancer treated with abemaciclib and endocrine therapy.

Clinical cancer research : an official journal of the American Association for Cancer Research·2026
Same author

Invest where impact begins: recommendations from Breast Cancer Research Foundation Early Career Investigator Working Group (Part 1 of 2).

NPJ breast cancer·2026